Clinical Relevance of Serum Periostin in Breast Cancer Diagnosis and Metastatic Risk Assessment

Authors

  • Amira Raafat Elsheikh , Abdelrahman Mohamed amin Sarhan , Radwa Abdou Mohamed , Marwa Mohammed Esawy

Keywords:

Serum Periostin, Breast Cancer, Metastasis

Abstract

Breast cancer remains the most prevalent malignancy among women worldwide and a leading cause ofcancer-related mortality. Despite advances in imaging and molecular diagnostics, there remains a need for reliable,minimally invasive biomarkers that can aid in early detection, monitor disease progression, and predict metastasis.Periostin (POSTN), a secreted extracellular matrix protein, has recently emerged as a promising candidate biomarker in

References

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN estimates. CA Cancer J Clin. 2021;71(3):209-249.

Rakha EA, Reis-Filho JS, Baehner F, et al. Breast cancer histologic grading: Past, present and future. Histopathology. 2010;57(3):219-231.

Downloads

Published

2024-06-20

How to Cite

Amira Raafat Elsheikh , Abdelrahman Mohamed amin Sarhan , Radwa Abdou Mohamed , Marwa Mohammed Esawy. (2024). Clinical Relevance of Serum Periostin in Breast Cancer Diagnosis and Metastatic Risk Assessment . Journal of Computational Analysis and Applications (JoCAAA), 33(06), 2295–2302. Retrieved from https://eudoxuspress.com/index.php/pub/article/view/3308

Issue

Vol. 33 No. 06 (2024): JOCAAA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.